dc.contributor.author | Güdücü, Nilgün | |
dc.contributor.author | Sidar, Güliz | |
dc.contributor.author | Başsüllü, Nuray | |
dc.contributor.author | Türkmen, İlknur | |
dc.contributor.author | Dünder, İlkkan | |
dc.date.accessioned | 2014-11-11T12:50:32Z | |
dc.date.available | 2014-11-11T12:50:32Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Guducu N, Sidar G, Bassullu N, Turkmen I, Dunder I. Three-step approach versus see-and-treat approach in patients with cytological abnormalities. International Journal of Clinical and Experimental Medicine. 2013; 6(5): 372-376. | en_US |
dc.identifier.issn | 1940-5901 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664005/ | en_US |
dc.identifier.uri | https://hdl.handle.net/11446/524 | en_US |
dc.description | İstanbul Bilim Üniversitesi, Tıp Fakültesi. | en_US |
dc.description.abstract | The aim of this study was to compare the results of see-and-treat procedure with the classical three-step procedure in terms of initial cytology and LEEP reports. We searched the pathology charts of patients that had LEEP were searched retrospectively and then they were divided into 2 groups according to the presence or absence of a cervical biopsy before LEEP. There were 116 patients in the study. Of the patients with ASCUS/LSIL cytology and a positive cervical biopsy 48.4% had CIN 2-3 at LEEP, in contrast only 19% of the patients without a prior cervical biopsy had CIN 2-3 at LEEP (p=0.031); there was no statistically significant difference between the 2 procedures in patients with a HSIL and ASC-H smear result (p=0.726 and p=1.0 respectively). In conclusion patients with ASC-H and HSIL cytology see-and-treat approach seems more advantageous, avoids delay in treatment, noncompliance and risk of skipping lesions at biopsy. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | e-Century Publishing Corporation | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | see-and-treat | en_US |
dc.subject | colposcopy | en_US |
dc.subject | CIN | en_US |
dc.subject | overtreatment | en_US |
dc.title | Three-step approach versus see-and-treat approach in patients with cytological abnormalities | en_US |
dc.type | article | en_US |
dc.relation.journal | International Journal of Clinical and Experimental Medicine | en_US |
dc.department | DBÜ, Tıp Fakültesi | en_US |
dc.identifier.issue | 5 | |
dc.identifier.volume | 6 | |
dc.identifier.startpage | 372 | |
dc.identifier.endpage | 376 | |
dc.contributor.authorID | TR123126 | en_US |
dc.contributor.authorID | TR186939 | en_US |
dc.contributor.authorID | TR26265 | en_US |
dc.contributor.authorID | TR183371 | en_US |
dc.contributor.authorID | TR26039 | en_US |
dc.relation.publicationcategory | Belirsiz | en_US |